Patents by Inventor Toomas Neuman

Toomas Neuman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040219575
    Abstract: Disclosed herein are compositions and methods for diagnosing cancer, determining cancer prognosis, and identifying cancer subtypes for a variety of cancers. Also disclosed herein are compositions and methods for the treatment of cancer.
    Type: Application
    Filed: December 24, 2003
    Publication date: November 4, 2004
    Inventors: Toomas Neuman, Kaia Palm
  • Publication number: 20030118566
    Abstract: The invention is directed to the field of human stem cells and includes methods and compositions for isolating, propagating, and differentiating human stem cells. The invention provides therapeutic uses of the methods and compositions, including autologous transplantation of treated cells into humans for treatment of Parkinson's and other neuronal disorders.
    Type: Application
    Filed: August 8, 2002
    Publication date: June 26, 2003
    Inventors: Toomas Neuman, Michel Levesque
  • Patent number: 6555369
    Abstract: The invention relates to the stable transfection of neurons with DNA encoding proliferating cell nuclear antigen (PCNA) and replication factor C (RFC). Also, co-transfection of a functional gene along with the DNA encoding PCNA and RFC causes stable integration of the functional gene.
    Type: Grant
    Filed: June 21, 2001
    Date of Patent: April 29, 2003
    Assignee: Spinal Cord Society
    Inventors: Toomas Neuman, Howard O. Nornes
  • Publication number: 20030027779
    Abstract: A method is provided for inducing DNA synthesis in differentiated neurons. According to certain embodiments of the invention, a method for inducing DNA synthesis in a differentiated neuron is provided that includes obtaining a vector comprising nucleic acid encoding an E2F regulator and/or an E1A regulator, wherein the vector can be used to express the nucleic acid in a differentiated neuron, and transfecting a differentiated neuron with the vector.
    Type: Application
    Filed: January 25, 2002
    Publication date: February 6, 2003
    Applicant: Spinal Cord Society
    Inventors: Toomas Neuman, Kikuo Suda, Howard O. Nornes
  • Patent number: 6372721
    Abstract: A method is provided for inducing DNA synthesis in differentiated neurons. According to certain embodiments of the invention, a method for inducing DNA synthesis in a differentiated neuron is provided that includes obtaining a vector comprising nucleic acid encoding an E2F regulator and/or an E1A regulator, wherein the vector can be used to express the nucleic acid in a differentiated neuron, and transfecting a differentiated neuron with the vector.
    Type: Grant
    Filed: September 30, 1999
    Date of Patent: April 16, 2002
    Assignee: Spinal Cord society
    Inventors: Toomas Neuman, Kikuo Suda, Howard O. Nornes
  • Publication number: 20020031832
    Abstract: The invention relates to the stable transfection of neurons with DNA encoding proliferating cell nuclear antigen (PCNA) and replication factor C (RFC). Also, co-transfection of a functional gene along with the DNA encoding PCNA and RFC causes stable integration of the functional gene.
    Type: Application
    Filed: June 21, 2001
    Publication date: March 14, 2002
    Applicant: Spinal Cord Society
    Inventors: Toomas Neuman, Howard O. Nornes
  • Patent number: 6268174
    Abstract: The invention relates to the stable transfection of neurons with DNA encoding proliferating cell nuclear antigen (PCNA) and replication factor C (RFC). Also, co-transfection of a functional gene along with the DNA encoding PCNA and RFC causes stable integration of the functional gene.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: July 31, 2001
    Assignee: Spinal Cord Society
    Inventors: Toomas Neuman, Howard O. Nornes
  • Patent number: 6087171
    Abstract: A method is provided for inducing DNA synthesis in differentiated neurons. According to certain embodiments of the invention, a method for inducing DNA synthesis in a differentiated neuron is provided that includes obtaining a vector comprising nucleic acid encoding an E2F regulator and/or an E1A regulator, wherein the vector can be used to express the nucleic acid in a differentiated neuron, and transfecting a differentiated neuron with the vector.
    Type: Grant
    Filed: November 18, 1996
    Date of Patent: July 11, 2000
    Assignee: Spinal Cord Society
    Inventors: Toomas Neuman, Kikuo Suda, Howard O. Nornes
  • Patent number: 6087168
    Abstract: The present invention is directed to method of converting, or transdifferentiating the epidermal cells into viable neurons useful in both cell therapy and gene therapy treatment methodologies. The method of transdifferentiating epidermal cells into neuronal cells comprises the following steps: obtaining skin cells from a patient; dedifferentiating these cells with an appropriate medium, neurotrophin or cytokine; transfecting the skin cells with one or more expression vector(s) encoding at least one neurogenic transcription factor or active fragments thereof; expressing at least one of the neurogenic transcription factors; growing the transfected cells in an appropriate medium; and adding to the medium one or more antisense oligonucleotide(s) corresponding to at least one negative regulator of neuronal differentiation, whereby the epidermal cells are transdifferentiated into neuronal cells.
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: July 11, 2000
    Assignee: Cedars Sinai Medical Center
    Inventors: Michel F. Levesque, Toomas Neuman
  • Patent number: 5880153
    Abstract: The present invention provides compositions and methods for inducing expression of neurotrophic factor receptors trkB and trkC in neurons. The compositions include a material that activates a nuclear hormone receptor, a material that activates the second messenger response system, and a material that elevates Ca.sup.2+.
    Type: Grant
    Filed: November 12, 1996
    Date of Patent: March 9, 1999
    Assignee: Spinal Cord Society
    Inventors: Toomas Neuman, Henry Connor, Howard O. Nornes